Dr. Olaf Stuve is a tenured Professor in the Department of Neurology at UT Southwestern Medical Center, Head of the MS/ Neuroimmunology section, and Chief of Neurology at the VA North Texas Health Care System/ Dallas VA Medical Center. In addition to his clinical activities, he has been the Principal Investigator and site Principal Investigator for numerous clinical trials. Dr. Stuve also runs a research laboratory at UT Southwestern, which is studying the differential molecular requirements for bone-marrow-derived leukocytes to cross the blood-brain barrier or other biological barriers that provide immune privilege for the central nervous system (CNS). He is also exploring molecular and cellular differences between bone-marrow-derived myeloid cell subsets and CNS-intrinsic microglia, and the potential pathogenic role of innate immune cells in early and late MS. Furthermore, Dr. Stuve’s research interests include molecular and cellular markers of autoimmunity, and experimental therapies for autoimmune disorders.
Dr. Stuve’s research has been supported by grants from the Department of Veterans Affairs, the National Multiple Sclerosis Society (NMSS), the Deutsche Forschungsgemeinschaft (DFG), and Boehringer Ingelheim Fonds. He has published over 300 research articles, review articles, editorials, and book chapters, and he has given over 200 invited presentations. Dr. Stuve has served on numerous editorial boards of medical and scientific journals, and he has been a member of National Institutes of Health (NIH), and National Multiple Sclerosis Society (NMSS) study sections. Dr. Stuve is a past associate editor of JAMA Neurology, and a past steering committee member of the Immune Tolerance Network (ITN).
